Innovative health technologies are the most cost-effective solutions to achieve the Sustainable Development Goals (SDGs), as they have the potential to save millions of lives. Research and development (R&D) for new health tools may play a critical role not only in ensuring healthy lives (SDG 3), but also in relieving poverty (SDG 1), contributing to drive economic growth (SDG 8), strengthening partnerships (SDG 17) and enhancing global health security.
Over the past few years, investments in global health R&D have delivered new health technologies that address a multitude of poverty-related and neglected diseases (PRNDs), which affect the most vulnerable populations. However, despite tremendous progress and millions of lives saved, PRNDs are still major killers. Furthermore, antimicrobial resistance is a major global concern. Thus, current global health R&D efforts are not enough to combat those threats and achieve the SDGs—new drugs, diagnotics, vaccines and health tools are urgently needed to tackle those global diseases.
The session will be moderated by M.P. Matsoso, Director-General of Health, Ministry of Health of South Africa.
For more information contact: Christina do Paço, Medicines for Malaria Venture, firstname.lastname@example.org.